MAPT and early-onset autosomal dominant Alzheimer disease: Plasma p-tau181 is a biomarker specific for Alzheimer’s disease tau pathology and correspondingly does not capture the full spectrum of the A/T/(N) framework as proposed by the National Institute of Aging-Alzheimer’s Association (NIA-AA).2